
Results
80
80 companies
Santen Pharmaceutical
Market Cap: JP¥514.4b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,599.50
7D
-0.8%
1Y
-7.1%
Emcure Pharmaceuticals
Market Cap: ₹268.1b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,414.30
7D
4.4%
1Y
3.6%
Yunnan Baiyao GroupLtd
Market Cap: CN¥100.0b
Engages in the pharmaceutical business in China.
000538
CN¥56.06
7D
0.7%
1Y
-2.2%
SK Biopharmaceuticals
Market Cap: ₩10.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩139,800.00
7D
10.5%
1Y
35.2%
Ajanta Pharma
Market Cap: ₹319.8b
A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.
AJANTPHARM
₹2,560.80
7D
3.0%
1Y
-15.3%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥30.3b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥45.48
7D
0.1%
1Y
41.0%
Samsung BiologicsLtd
Market Cap: ₩74.4t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,607,000.00
7D
-14.4%
1Y
7.2%
WuXi Biologics (Cayman)
Market Cap: HK$128.3b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$31.16
7D
2.0%
1Y
107.7%
Shionogi
Market Cap: JP¥2.3t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,680.50
7D
-0.6%
1Y
26.5%
Dottikon ES Holding
Market Cap: CHF 4.9b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.
DESN
CHF 354.50
7D
9.6%
1Y
52.1%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹277.3b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,770.65
7D
2.5%
1Y
2.0%
Krystal Biotech
Market Cap: US$6.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$218.00
7D
2.8%
1Y
10.4%
Vericel
Market Cap: US$2.0b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$40.25
7D
1.7%
1Y
-30.8%
Zoetis
Market Cap: US$56.5b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZTS
US$128.18
7D
5.0%
1Y
-26.9%
Siegfried Holding
Market Cap: CHF 3.2b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 72.00
7D
0.8%
1Y
-35.4%
Waters
Market Cap: US$24.0b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$403.42
7D
2.4%
1Y
4.9%
Gilead Sciences
Market Cap: US$156.1b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$125.84
7D
-0.6%
1Y
35.9%
Lotus Pharmaceutical
Market Cap: NT$82.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$312.00
7D
11.2%
1Y
7.0%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥44.2b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥98.29
7D
2.9%
1Y
60.8%
Jilin Aodong Pharmaceutical Group
Market Cap: CN¥22.4b
Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
CN¥19.10
7D
1.0%
1Y
3.9%
Kalbe Farma
Market Cap: Rp54.4t
Develops, manufactures, and trades in pharmaceutical products in Indonesia.
KLBF
Rp1,200.00
7D
-0.8%
1Y
-20.0%
Sai Life Sciences
Market Cap: ₹185.9b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹884.40
7D
2.7%
1Y
n/a
Alkem Laboratories
Market Cap: ₹679.7b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,685.00
7D
-0.3%
1Y
0.8%
Halozyme Therapeutics
Market Cap: US$8.4b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$71.40
7D
1.5%
1Y
48.1%
Abbott India
Market Cap: ₹639.0b
Operates as a pharmaceutical company in India.
500488
₹30,069.35
7D
1.7%
1Y
8.4%
Eris Lifesciences
Market Cap: ₹217.3b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,595.40
7D
-4.2%
1Y
10.8%
Camurus
Market Cap: SEK 36.8b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 617.00
7D
1.6%
1Y
8.2%
PharmaEssentia
Market Cap: NT$190.8b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$516.00
7D
10.4%
1Y
-1.4%
Shanghai Henlius Biotech
Market Cap: HK$37.5b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$69.05
7D
8.2%
1Y
221.2%
Shenzhen Salubris Pharmaceuticals
Market Cap: CN¥69.0b
Shenzhen Salubris Pharmaceuticals Co., Ltd.
002294
CN¥61.85
7D
2.9%
1Y
77.7%
CSL
Market Cap: AU$90.0b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$186.30
7D
4.2%
1Y
-34.0%
Dong-E-E-JiaoLtd
Market Cap: CN¥30.4b
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.
000423
CN¥47.27
7D
-1.8%
1Y
-18.4%
BioArctic
Market Cap: SEK 27.0b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 304.60
7D
9.2%
1Y
57.7%
argenx
Market Cap: €47.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€782.40
7D
-2.2%
1Y
33.4%
Bavarian Nordic
Market Cap: DKK 14.5b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 184.75
7D
0.4%
1Y
-4.5%
ALK-Abelló
Market Cap: DKK 51.1b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 230.80
7D
1.5%
1Y
42.5%